InBody Co

InBody Co Equity Growth

The Year-over-Year Equity Growth of InBody Co (041830.KQ) as of Oct 26, 2026 is 16.44 %. In the previous year, Year-over-Year Equity Growth was 9.73 % — a change of 69.01% (higher).

Equity Growth

16.44 %

YoY

69.01%

Last updated:

Year-over-Year Equity Growth of InBody Co is 2025 16.44 % . Year-over-Year Equity Growth of InBody Co was 2024 9.73 % . It decreases by 69.01% higher compared to the previous year.

The InBody Co Equity Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Growth
Date
Equity Growth
Jan 1, 2018
16.82 KRW
Jan 1, 2019
12.31 KRW
Jan 1, 2020
7.43 KRW
Jan 1, 2021
22.44 KRW
Jan 1, 2022
17.16 KRW
Jan 1, 2023
15.57 KRW
Jan 1, 2024
9.73 KRW
Jan 1, 2025
16.44 KRW
The InBody Co Equity Growth history
YEAREquity GrowthYoY
16.44 %+69.01%
9.73 %-37.50%
15.57 %-9.28%
17.16 %-23.53%
22.44 %+202.17%
7.43 %-39.66%
12.31 %-26.84%
16.82 %+9.50%
15.36 %-26.64%
20.94 %-25.44%
28.08 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

InBody Co Stock analysis

What does InBody Co do? InBody Co., Ltd. generates revenue through the sale of body composition analyzers under the InBody and Lookin’Body brand names. The InBody series includes models such as InBody720, InBody520, InBody230, InBody R20, InBody S20, InBody S10, and InBody J10, while the Lookin’Body series offers Lookin’Body3.0 and Lookin’Body Basic for measuring proteins, minerals, fats, and moisture. The company also sells BMI measuring devices under the BSM brand. Products are distributed domestically and internationally to meet demand in both markets. The primary customers for InBody’s equipment are healthcare facilities, fitness centers, and wellness providers seeking accurate body composition data. The InBody series targets professional and clinical settings, whereas Lookin’Body products cater to general wellness and fitness applications. BSM devices serve as complementary tools for body mass index tracking in similar environments. InBody Co., Ltd. focuses on selling medical equipment directly to end-users and distributors, with no mention of third-party partnerships or additional revenue streams. The company’s product portfolio is designed to address diverse needs within the health and fitness industry, leveraging its established brand names for market penetration. InBody Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about InBody Co stock

Year-over-Year Equity Growth of InBody Co is 16.44 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year Equity Growth InBody Co since 2006 – with annual values, charts, and detailed analysis.

Equity growth measures the percentage change in shareholders' equity. It reflects retained earnings, share issuances, and comprehensive income effects.

To evaluate Year-over-Year Equity Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Equity Growth.

Year-over-Year Equity Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Equity Growth's InBody Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Growth — InBody Co

Revenue GrowthRevenue CAGR 3YRevenue CAGR 5YRevenue CAGR 10YEarnings GrowthEPS GrowthEBIT GrowthEBIT CAGR 3YEBIT CAGR 5YEBIT CAGR 10YDividend GrowthFCF GrowthBook Value GrowthEarnings CAGR 3YEarnings CAGR 5YEarnings CAGR 10YEPS CAGR 3YEPS CAGR 5YEBITDA Growth YoYEBITDA CAGR 3YEBITDA CAGR 5YGross Profit GrowthOCF Growth YoYEmployee GrowthDividend CAGR 3YDividend CAGR 5YDividend CAGR 10YAsset GrowthEquity GrowthDebt GrowthCapEx GrowthFCF CAGR 3YFCF CAGR 5YMarket Cap GrowthShare Count Growth

All Key Metrics — InBody Co